MET and head and neck squamous cell carcinoma: We recently demonstrated the existence of a signaling network involving EGFR, ERBB2, FGFRs, and MET in HNSCC cell lines where synergistic growth inhibition can be achieved with combinations of TKIs inhibiting all these RTKs [24].